Crossmark

Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation

Crossref DOI link: https://doi.org/10.1186/s12882-018-1068-1

Published Online: 2018-10-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Riley, Alyssa A.

Watson, Mary

Smith, Carolyn

Guffey, Danielle

Minard, Charles G.

Currier, Helen

Akcan Arikan, Ayse http://orcid.org/0000-0002-5123-6713
License Information

Text and Data Mining valid from 2018-10-19
More Information

Article History

Received: 15 December 2017

Accepted: 4 October 2018

First Online: 19 October 2018

Ethics approval and consent to participate

: The study was performed at Texas Children’s Hospital, Houston, TX with the prior approval of the Baylor College of Medicine Internal Review Board as study H-32217. Due to the retrospective nature of the study, an exemption from need to obtain individual consent was granted.

: Not applicable.

: Baylor College of Medicine received payments in 2013 totaling $8587.68 from Amgen, Inc. under Dr. Alyssa Riley’s name while she was the site PI for two of their sponsored pediatric cinacalcet studies.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.